
Proactive12d agobullish
Citi backs AstraZeneca sentiment boost after Etcamah wins accelerated FDA approvalCiti has flagged AstraZeneca PLC's (LSE:AZN, NASDAQ:AZN) accelerated approval for Etcamah, known chemically as camizestrant, as a meaningful sentiment driver for the shares. The oral selective oestrogen receptor degrader has been cleared by the US Food and Drug Administration in combination...